Profound Medical Corp.PROFNASDAQ
Loading
Free Cash Flow Growth TrendStable
Percentile Rank85
5Y CAGR-21.0%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
-21.0%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q4 2025 | 30.74% |
| Q3 2025 | 32.62% |
| Q2 2025 | -69.86% |
| Q1 2025 | -46.81% |
| Q4 2024 | 17.35% |
| Q3 2024 | -9.76% |
| Q2 2024 | -37.32% |
| Q1 2024 | 35.46% |
| Q4 2023 | -61.76% |
| Q3 2023 | 15.26% |
| Q2 2023 | 12.09% |
| Q1 2023 | 12.07% |
| Q4 2022 | -15.07% |
| Q3 2022 | -3.36% |
| Q2 2022 | 29.15% |
| Q1 2022 | -51.72% |
| Q4 2021 | -0.78% |
| Q3 2021 | 16.84% |
| Q2 2021 | 4.20% |
| Q1 2021 | 0.00% |
| Q4 2020 | 100.00% |
| Q3 2020 | -161.30% |
| Q2 2020 | 77.08% |
| Q1 2020 | -27.18% |
| Q4 2019 | -130.29% |
| Q3 2019 | 49.24% |
| Q2 2019 | -100.38% |
| Q1 2019 | 9.21% |
| Q4 2018 | 30.70% |
| Q3 2018 | 5.75% |
| Q2 2018 | -41.06% |
| Q1 2018 | 18.54% |
| Q4 2017 | -52.26% |
| Q3 2017 | 31.15% |
| Q2 2017 | -14.50% |
| Q1 2017 | 14.94% |
| Q4 2016 | -39.37% |
| Q3 2016 | 19.61% |
| Q2 2016 | -21.00% |
| Q1 2016 | -142.64% |